Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 3, Pages 521
Publisher
MDPI AG
Online
2019-01-29
DOI
10.3390/ijms20030521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity
- (2017) Deepkamal N. Karelia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity
- (2016) Verónica Alcolea et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines
- (2016) Verónica Alcolea et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selenium compounds as therapeutic agents in cancer
- (2015) Aristi P. Fernandes et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Targeting drivers of melanoma with synthetic small molecules and phytochemicals
- (2015) Leah Ray Strickland et al. CANCER LETTERS
- The use of interferon in melanoma patients: A systematic review
- (2015) Rossella Di Trolio et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Melanoma Treatments: Advances and Mechanisms
- (2015) Alexander Marzuka et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells
- (2015) Nabanita Mukherjee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Critical role of STAT3 in melanoma metastasis through anoikis resistance
- (2015) Neel M. Fofaria et al. Oncotarget
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
- (2013) Fang Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Discovery of Novel STAT3 Small Molecule Inhibitors via in Silico Site-Directed Fragment-Based Drug Design
- (2013) Wenying Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor
- (2013) T M Becker et al. ONCOGENE
- Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
- (2013) YANG WANG et al. ONCOLOGY REPORTS
- Selenium for the Prevention of Cutaneous Melanoma
- (2013) Pamela Cassidy et al. Nutrients
- Is Selenium a Potential Treatment for Cancer Metastasis?
- (2013) Yu-Chi Chen et al. Nutrients
- Cytotoxic and Proapototic Activities of Imidoselenocarbamate Derivatives Are Dependent on the Release of Methylselenol
- (2012) Alicia Zuazo et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
- (2012) Maria R. Girotti et al. Cancer Discovery
- Melanoma Prevention Using Topical PBISe
- (2011) C.-Y. Chung et al. Cancer Prevention Research
- Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4
- (2010) N. Nguyen et al. Cancer Prevention Research
- Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates
- (2010) Elena Ibáñez et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
- (2010) G. Ishdorj et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates
- (2009) A. Sharma et al. CLINICAL CANCER RESEARCH
- Synthesis and Anticancer Activity Comparison of Phenylalkyl Isoselenocyanates with Corresponding Naturally Occurring and Synthetic Isothiocyanates
- (2008) Arun K. Sharma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
- (2008) Carmen Sanmartin et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- PBISe, a novel selenium-containing drug for the treatment of malignant melanoma
- (2008) S. V. Madhunapantula et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design, synthesis, and studies of small molecule STAT3 inhibitors
- (2007) Deepak Bhasin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started